Certara Products - Simcyp Archives | Page 2 of 24

Press Release

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara announces that EMA has formally qualified the Simcyp® Simulator for use in regulatory submissions…

CertaraAugust 4, 2025

Webinar

Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese]

CertaraJuly 30, 2025

On-Demand Webinar

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.

CertaraJuly 29, 2025

On-Demand Webinar

Boosting Confidence in Drug Discovery with PBPK

Explore Simcyp Discovery Version 2 updates to boost early-stage drug development.

CertaraJuly 25, 2025

Blog

How Pharma Can Transition to Non-animal Studies for Investigational Drugs

Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…

CertaraJuly 25, 2025

Conference

AusBiotech International Conference 2025

Danielle PillsburyJuly 25, 2025

Press Coverage

The end of animal testing? Transitioning to models is promising — but no silver bullet

The FDA has stated that the pharma industry must transition to using in vitro assays,…

CertaraJuly 21, 2025

On-Demand Webinar

Certara’s Simcyp Educational Webinar Series Part 3: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling & Simulation Approaches [in Japanese]

Learn PBBM fundamentals and supersaturated dissolution modeling in Japanese with Dr. Kambayashi—ideal for CMC and…

CertaraJuly 16, 2025

Press Coverage

How is the pharmaceutical industry addressing global health inequities?

Explore Karen Rowland Yeo's insights on using Model-Informed Drug Development to address global health equities…

CertaraJune 17, 2025

Blog

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

With the release of the draft ICH M15 guidance, MIDD is no longer optional -…

CertaraJune 11, 2025

Certara Products – Simcyp

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese]

MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines

Boosting Confidence in Drug Discovery with PBPK

How Pharma Can Transition to Non-animal Studies for Investigational Drugs

AusBiotech International Conference 2025

The end of animal testing? Transitioning to models is promising — but no silver bullet

Certara’s Simcyp Educational Webinar Series Part 3: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling & Simulation Approaches [in Japanese]

How is the pharmaceutical industry addressing global health inequities?

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Newsletter sign up

Quick links

Solutions

Contact